Stocks Listing
CUV.AX

Clinuvel Pharmaceuticals Limited

Share
CUV.AX
$14.63 0.68%Last Updated Nov 25 2022 04:56 AM
1D Low / 1D High
Low:$14.58
High:$14.80
1D
0.68%
5D
0.07 %
30D
3.41 %
BulletPurple
Market Cap
$722,927,427
0.22 %
722.9 M
BulletBlue
Volume 1D
17,783
-
17.8 K
BulletOrange
Circulating Supply
49,410,300 CUV.AX
49.4 M

Price Chart

1D
5D
1M
6M
YTD
1Y
MAX
About

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke increased and prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited t to treat EPP patients with SCENESSE under a named patient program in the People's Republic of China. The company was founded in 1987 and is headquartered in Melbourne, Australia.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open - Close
Low/High
Volume
Market Cap
Show More
Market Status
Closed
ASX
National Stock Exchange of Australia
AUS
Opens in
6 hours, 9 minutes
Working Hours
Sun-Fri, 11:00 PM - 05:00 AM
Timezone
GMT+0